Case Study
Case Study  1 : Cerebellopontine Angle Haemangioblastoma Successfully Treated
with CyberKnife
®  >>
Case Study  2 : CyberKnife®  for Hypothalamic Hamartoma  >>
Case Study  3 :
Breast Carcinoma with Lung Metastasis
Case Study  4 :
Rectal Carcinoma with Lung Metastasis
Case Study  5 :
Breast Carcinoma with Spine Metastasis
Case Study  6 : CyberKnife® for Inoperable Cholangiocarcinoma  >>
Case Study  7 :
Breast Carcinoma with Solitary Liver Metastasis
Case Study  8 :
Lung Cancer Treated
with CyberKnife
®  >>
Case Study 9 :
Cyberknife in Prostate cancer
Case Study 9 : Cyberknife in Prostate cancer
An 81-year-old male was presented to Apollo Speciality Cancer Hospital with symptoms of prostatism (urgency and hesitancy in urination). The patient's serum PSA was 6.25 ng/dL. CT scan of prostate showed a nodule in the right lobe of the prostate without capsular breach and no pelvic nodal enlargement. Transrectal biopsy from the prostate confirmed the malignancy (adenocarcinoma, Gleason score 7 [4+3]). Metastatic work up was negative.

The patient was diagnosed with localised prostate cancer and was planned for CyberKnife® treatment. He received 36.25Gy in five fractions over 1 week with CyberKnife®. The patient completed the treatment without any severe acute toxicity and was not treated with hormonal medicines. Follow-up after 3 months of CyberKnife® showed 3.1 ng/dL PSA, and there was complete radiological response to the prostate nodule.
Home  |  Contact  
Apollo Hospitals  >>  Apollo Speciality Cancer Hospital  >> << Click here to view Cyberknife Blog >>